Natco Pharma LimitedNSE: NATCOPHARM

Natco Pharma Limited Press Release Jul 18 2026

· Issued by Natco Pharma Limited via NSE India

Natco Pharma Limited has informed the Exchange regarding a press release dated July 18, 2026, titled "NATCO received Tentative Approval for Olaparib Tablets from the United States Food and Drug Administration (U.S. FDA)".

View Attachment

Earlier from Natco Pharma

All Natco Pharma news releases